Modular Medical, Inc. (MODD) AI Stock Summary

Snapshot

Modular Medical is a pre-revenue medical device company launching its first insulin pump. FY 2026 revenue was $0 with a net loss of $28.2M. Free cash flow was negative $27.7M, consuming the entire $6.9M cash balance in weeks at current burn rates. The company executed a 1-for-30 reverse split in March 2026 and its auditors raised substantial doubt about its ability to continue as a going concern.

What's Happening Right Now

• Mon 3rd Aug '26 · Expansion: The company announced plans to launch its Pivot insulin delivery system across five U.S. markets including Atlanta and Dallas beginning in October 2026.
• Thu 23rd Jul '26 · Strategy: The company formed a Pivot Innovation Council chaired by Dr. Robert Gabbay to guide clinical and commercial strategy.
• Thu 16th Jul '26 · Partnership: Modular Medical partnered with IMO Health on a pilot to identify insulin pump patients directly within electronic health records.
• Tue 30th Jun '26 · Filing: The company's 10-K raised substantial doubt about its ability to continue as a going concern and disclosed a 1-for-30 reverse split effective March 31, 2026.
• Tue 30th Jun '26 · Milestone: Modular Medical delivered insulin to the first patients using its Pivot tubeless patch pump, marking its transition from development to commercial operations.

Ownership

Institutions hold 1.0% of shares while insiders hold 0.4%.

Bottom Line

Modular Medical has achieved its goal of launching the Pivot insulin pump, but the financial condition is critical. With a cash runway of less than one month and a formal going-concern warning, the company faces immediate survival risks despite its product milestones. The recent 1-for-30 reverse split signals the stock has been under severe pressure. This is a highly speculative situation where the business must raise capital immediately to continue operating.